Mortality and Functional Disability After Spontaneous Intracranial Hemorrhage: the Predictive Impact of Overall Admission Factors
Overview
Authors
Affiliations
To determine the effects of different prognostic factors, including previous antiplatelet therapy, admission data, and radiographic findings on discharge and 3-month neurological condition using modified Rankin scale (mRS) and mortality at 30 days and 3-month follow-up in patients presenting to the emergency department with spontaneous intracranial hemorrhage (sICH). Between January and July 2012, 120 consecutive patients (males 62%, females 38%), who were admitted within 48 h of symptoms onset, were included. We recorded the following data on admission: demographics; functional scores of ICH, Glasgow Coma Scale, and National Institutes of Health Stroke Scale; vital signs; smoking status; use of illicit drug; preadmission antiplatelet treatment; results of laboratory tests (platelet count, serum glucose, sodium and creatinine levels, and prothrombin time); and primary neuroimaging findings [intraventricular hemorrhage (IVH), midline shift, and hydrocephalus]. In multivariate analysis using adjusted model for demographics and prior antiplatelet therapy; functional scores, laboratory results, and diabetes history correlated with mortality during 30 days after the event. Moreover, the parameters on the initial computed tomography scan significantly increased 30-day fatality rate and was correlated with increase in the discharge mRS score of survivors. The odds ratio (OR) and 95% confidence interval (CI) of early mortality associated with IVH presentation was 2.34 (CI 1.76-3.02, p = 0.003). The corresponding ORs in those with midline shift displacement and hydrocephalus were 2.18 (95% CI 2.08-3.80, p = 0.01) and 1.62 (95% CI 1.01-2.63, p = 0.02), respectively. In patients with ICH, prognostic factors, include various clinical parameters and paraclinical findings of admission time.
Sasongko A, Perdana Wahjoepramono P, Halim D, Aviani J, Adam A, Tseng Tsai Y PLoS One. 2025; 20(2):e0315333.
PMID: 39970158 PMC: 11838903. DOI: 10.1371/journal.pone.0315333.
Qian A, Zheng L, He Z, Zhou J, Tang S, Xing W Front Neurol. 2024; 15:1301197.
PMID: 38333609 PMC: 10851875. DOI: 10.3389/fneur.2024.1301197.
Perdana Wahjoepramono P, Sasongko A, Halim D, Aviani J, Lukito P, Adam A World Neurosurg X. 2023; 19:100194.
PMID: 37359762 PMC: 10288487. DOI: 10.1016/j.wnsx.2023.100194.
Chong S, Zhao P, Huang R, Zhou H, Zhang J, Hou M Blood Adv. 2022; 6(14):4320-4329.
PMID: 35679462 PMC: 9327537. DOI: 10.1182/bloodadvances.2022007226.
Wu Y, Zhang D, Chen H, Liu B, Zhou C Front Neurol. 2021; 12:691357.
PMID: 34497575 PMC: 8419415. DOI: 10.3389/fneur.2021.691357.